NOS1 and neoplasm: However, our in vivo study demonstrated that co-administration of KK-11 with the selective nNOS inhibitor MAC-3-190 significantly reduced tumor growth compared to control and MAC-3-190 alone (Figure 5A), while this antitumor activity was not observed with low-dose MAC-3-190 treatment alone.